Join us on 10th June for an insightful discussion on pharmacogenetics—the study of how our genetic makeup influences our response to medications. Learn how this growing field is shaping personalized healthcare and what it means for individuals, particularly those of Jewish ancestry, who may have unique genetic factors affecting drug metabolism.
We are pleased to welcome Dr. Stuart Scott from the Stanford University School of Medicine, who will explore the role of genetics in medication response and its implications for patient care.
We’ll also be joined by a representative from the Medicines and Healthcare products Regulatory Agency (MHRA) to discuss the Yellow Card Biobank Study—a pioneering initiative using genetic data to enhance drug safety and regulation in the UK.
Don’t miss this opportunity to learn how science and regulation are coming together to improve health outcomes through personalized medicine.
